Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301 | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 11 May 2021